Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honglin Chen

Showing results (461-470 of 468) with videos related to

Pageof 47
Sort By:
You have reached the last page of results.This site can display upto 468 results.
The Lancet. Infectious Diseases|March 28, 2020
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyKelvin Kai-Wang To, Owen Tak-Yin Tsang, Wai-Shing Leung, et al.
Science (New York, N.Y.)|June 23, 2022
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamstersShuofeng Yuan, Zi-Wei Ye, Ronghui Liang, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 21, 2026
Novel Anti-BNLF2b Antibody Screening and Early Detection of Nasopharyngeal CarcinomaWan-Lun Hsu, Jiabao Tang, Hoi Yan Lam, et al.
Nature Communications|November 9, 2018
Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinomaWeitao Lin, Yim Ling Yip, Lin Jia, et al.
Nature Nanotechnology|January 21, 2026
Engineered mucus-tethering bispecific nanobodies enhance mucosal immunity against respiratory pathogensLiming Zhao, Kyle L O'Donnell, Megha Dubey, et al.
Nature|March 17, 2021
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2Shuofeng Yuan, Xin Yin, Xiangzhi Meng, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal modelsJessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, et al.
Cell|April 9, 2021
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammationJessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, et al.
Pageof 47

Showing results (461-470 of 468) with videos related to

Sort By:
Pageof 47
You have reached the last page of results.This site can display upto 468 results.
The Lancet. Infectious Diseases|March 28, 2020
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyKelvin Kai-Wang To, Owen Tak-Yin Tsang, Wai-Shing Leung, et al.
Science (New York, N.Y.)|June 23, 2022
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamstersShuofeng Yuan, Zi-Wei Ye, Ronghui Liang, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 21, 2026
Novel Anti-BNLF2b Antibody Screening and Early Detection of Nasopharyngeal CarcinomaWan-Lun Hsu, Jiabao Tang, Hoi Yan Lam, et al.
Nature Communications|November 9, 2018
Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinomaWeitao Lin, Yim Ling Yip, Lin Jia, et al.
Nature Nanotechnology|January 21, 2026
Engineered mucus-tethering bispecific nanobodies enhance mucosal immunity against respiratory pathogensLiming Zhao, Kyle L O'Donnell, Megha Dubey, et al.
Nature|March 17, 2021
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2Shuofeng Yuan, Xin Yin, Xiangzhi Meng, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal modelsJessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, et al.
Cell|April 9, 2021
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammationJessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, et al.
Pageof 47